All articles A–Z
519,064 articles
Pulmonary artery hypoplasia
Pulmonary artery hypoplasia is a rare congenital anomaly in which a branch pulmonary artery is underdeveloped, causing shortness of breath, recurrent lung infections, and pulmonary hypertension.
Pulmonary artery pressure monitoring
Pulmonary artery pressure monitoring is hemodynamic monitoring in which a small implantable sensor in a pulmonary artery measures blood pressure remotely, allowing heart failure treatment to be adjusted before congestion worsens.
Pulmonary aspiration
Pulmonary aspiration: entry of oropharyngeal or gastric material into the lower airway. Causes chemical pneumonitis (Mendelson's syndrome) or aspiration pneumonia; key risks are dysphagia, stroke, anesthesia, and reduced consciousness.
Pulmonary atresia
Congenital pulmonary atresia: a critical congenital heart defect in which the pulmonary valve does not form, blocking right ventricular blood flow to the lungs; two types (with intact ventricular septum or with VSD), about 1 in 8,333 US births, treated with prostaglandin, shunts, and staged surgery.
Pulmonary atresia with intact ventricular septum
Pulmonary atresia with intact ventricular septum (PA-IVS) is a rare congenital heart defect in which the pulmonary valve fails to develop, causing cyanosis in newborns.
Pulmonary atresia with ventricular septal defect
Pulmonary atresia with ventricular septal defect (PA/VSD), also called PA-VSD, is a critical congenital heart defect with an absent pulmonary valve and a VSD, often supplied by MAPCAs, repaired by unifocalization.
Pulmonary auscultation
Pulmonary auscultation is a physical examination method in which a stethoscope placed on the chest wall detects abnormal breath sounds, supporting diagnosis of pneumonia, heart failure, and pneumothorax.
Pulmonary blastoma
Pulmonary blastoma (pneumoblastoma) is a rare adult biphasic sarcomatoid lung cancer mimicking fetal lung, under 0.25% of lung tumors, ~350 reported cases, treated by surgery, distinct from childhood pleuropulmonary blastoma.
Pulmonary capillaritis
Pulmonary capillaritis (alveolar capillaritis) is neutrophilic inflammation and necrosis of alveolar capillary walls causing diffuse alveolar hemorrhage, usually from ANCA-associated vasculitis or collagen vascular disease, rarely isolated.
Pulmonary capillary hemangiomatosis
Pulmonary capillary hemangiomatosis (PCH), grouped with PVOD as PVOD/PCH, is a rare pulmonary vascular disease of abnormal alveolar capillary proliferation causing pulmonary hypertension, linked to biallelic EIF2AK4 mutations, treated by lung transplantation.
Pulmonary circulation
Pulmonary circulation carries deoxygenated blood from the right ventricle through the pulmonary arteries to the lungs and returns oxygenated blood to the left atrium; a low-pressure, low-resistance circuit first described by Ibn Al-Nafis.
Pulmonary collapse
Pulmonary collapse, or atelectasis, is deflation of part or all of a lung to an airless state, usually after anesthesia; distinct from pneumothorax, ICD-11 CB40.2, treated by reexpansion.
Pulmonary contusion
Pulmonary contusion: trauma-induced lung hemorrhage and edema without laceration, usually from blunt chest trauma; diagnosed by CT, treated supportively with oxygen, analgesia, and lung-protective ventilation; complications include pneumonia and ARDS.
Pulmonary cryptococcosis
Pulmonary cryptococcosis, lung infection from inhaled Cryptococcus neoformans or gattii spores, causing nodules, cough, often asymptomatic; treated with fluconazole or amphotericin B plus flucytosine.
Pulmonary Diffusing Capacity
Pulmonary diffusing capacity (DLCO, TLCO) measures carbon monoxide transfer from alveoli to blood, reflecting membrane area, capillary blood volume, and hemoglobin; developed by Marie Krogh in 1915 and standardized by Ogilvie in 1957.
Pulmonary edema
Pulmonary edema, abnormal fluid accumulation in lung interstitium and alveoli, occurs as cardiogenic (hydrostatic, left heart failure) or noncardiogenic (permeability, ARDS) types, distinguished by edema fluid protein ratio, wedge pressure, BNP, and imaging, and treated with oxygen, diuretics, nitrates, and ventilation.
Pulmonary embolectomy
Pulmonary embolectomy is a surgical or catheter-based procedure that removes thrombus from the pulmonary arteries in life-threatening pulmonary embolism, used when thrombolysis is contraindicated or has failed.
Pulmonary embolism
Acute pulmonary thromboembolism (pulmonary embolism, PE): sudden blockage of lung arteries by a clot, usually from leg deep vein thrombosis. Diagnosed by D-dimer and CTPA; treated with anticoagulation, classified A–E by the 2026 AHA/ACC guideline.
Pulmonary eosinophilia
Pulmonary eosinophilia (PIE syndrome, eosinophilic pneumonia): eosinophil infiltration of lung airways, interstitium, and alveoli; diagnosed by BAL over 25% eosinophils, blood eosinophilia with opacities, or biopsy; treated by cause.
Pulmonary fibrosis
Pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF), is scarring of lung tissue that impairs oxygen transfer. Known causes include drugs, radiation, environmental, occupational, and autoimmune disease; antifibrotics slow progression.
Pulmonary function testing
Pulmonary function testing (PFT), also called lung function testing, measures airflow, lung volumes, and gas transfer (DLCO) via spirometry, body plethysmography, and diffusing capacity, with impulse oscillometry as an effort-free complement, standardized by ATS/ERS 2019-2023 technical standards.
Pulmonary heart disease
Pulmonary heart disease (cor pulmonale) is right ventricular hypertrophy, dilatation, and failure caused by lung disorders producing pulmonary hypertension, chiefly COPD; left heart and congenital causes are excluded, and treatment targets the underlying lung disease and oxygenation.
Pulmonary histoplasmosis capsulati
Pulmonary histoplasmosis capsulati (ICD-11 1F2A.0) is lung infection from inhaling Histoplasma capsulatum var. capsulatum spores in bird- or bat-contaminated soil; endemic in the Ohio and Mississippi River valleys, usually self-limiting, treated with amphotericin B and itraconazole when severe.
Pulmonary hypertension
Pulmonary hypertension is abnormally high blood pressure in the arteries carrying blood from the heart's right side to the lungs, affecting about 1% of the global population and diagnosed by right heart catheterisation.
Pulmonary hypertension due to left heart disease (Group 2)
Pulmonary hypertension due to left heart disease (Group 2) is pulmonary hypertension caused by elevated left-sided pressures from heart failure or valve disease, the most common form.
Pulmonary hypertension due to lung disease and hypoxia (Group 3)
Pulmonary hypertension due to lung disease and hypoxia (Group 3) is a clinical group of pulmonary hypertension caused by lung diseases like COPD and interstitial lung disease, or low oxygen.
Pulmonary insufficiency
Pulmonary insufficiency, or pulmonary (pulmonic) regurgitation, is leaky closure of the pulmonary valve causing backflow into the right ventricle. Main causes: pulmonary hypertension and tetralogy of Fallot repair; treated by surgical or transcatheter pulmonary valve replacement.
Pulmonary interstitial glycogenosis
Pulmonary interstitial glycogenosis (PIG), also called infantile cellular interstitial pneumonitis, is a rare infant lung disease in which glycogen-filled mesenchymal cells widen the lung interstitium, presenting with respiratory distress.
Pulmonary Langerhans cell histiocytosis
Pulmonary Langerhans cell histiocytosis (PLCH) is a rare smoking-related interstitial lung disease in which clonal myeloid cells form nodules that evolve into cysts, mostly in adult smokers.
Pulmonary metastasectomy
Pulmonary metastasectomy is the surgical removal of lung tumors that have spread from a cancer elsewhere in the body, performed in a small share of eligible patients.